Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director departure

Juno Therapeutics, Inc. (JUNO) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/13/2019 SC 13G/A Capital International Investors reports a 0% stake in Juno Therapeutics Inc.
03/09/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
03/09/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2018 SC 13G/A VANGUARD GROUP INC reports a 6.1% stake in Juno Therapeutics Inc
02/02/2018 SC 13G/A Arch Venture Fund VII LP reports a 9.3% stake in Juno Therapeutics, Inc.
01/10/2018 SC 13G/A BAILLIE GIFFORD & CO reports a 9.2% stake in Juno Therapeutics, Inc.
02/14/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
01/27/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
02/11/2016 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy